Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 156,400 | 166,300 | 150,500 | 149,100 | 145,700 |
Cost of Goods | 65,300 | 76,400 | 69,500 | 64,600 | 64,200 |
Gross Profit | 91,100 | 89,900 | 81,000 | 84,500 | 81,500 |
Operating Expenses | 98,400 | 93,300 | 91,900 | 97,200 | 99,300 |
Operating Income | -7,000 | -3,000 | -10,400 | -12,100 | -17,600 |
Interest Expense | 8,800 | 8,100 | 8,100 | 7,800 | 7,600 |
Other Income | 1,000 | 900 | 700 | 500 | 400 |
Pre-tax Income | -14,800 | -10,200 | -17,800 | -19,400 | -24,800 |
Income Tax | -3,500 | -14,600 | -7,600 | -8,000 | -9,900 |
Net Income Continuous | -11,300 | 4,400 | -10,200 | -11,400 | -14,900 |
Net Income Discontinuous | 31,500 | 28,400 | 26,800 | 28,500 | 27,700 |
Net Income | $20,200 | $32,800 | $16,600 | $17,100 | $12,800 |
EPS Basic Total Ops | 0.43 | 0.70 | 0.35 | 0.37 | 0.27 |
EPS Basic Continuous Ops | -0.24 | 0.09 | -0.22 | -0.24 | -0.32 |
EPS Basic Discontinuous Ops | 0.67 | 0.61 | 0.57 | 0.61 | 0.59 |
EPS Diluted Total Ops | 0.43 | 0.69 | 0.35 | 0.37 | 0.27 |
EPS Diluted Continuous Ops | -0.24 | 0.09 | -0.22 | -0.24 | -0.32 |
EPS Diluted Discontinuous Ops | 0.67 | 0.60 | 0.57 | 0.61 | 0.59 |
EBITDA(a) | $800 | $8,000 | $5,700 | $4,100 | $-1,400 |